Ruling Could Affect Equine Drug Testing Regulations
Ron Mitchell/The Horse
August 27, 2011
A New York Supreme Court ruling regarding that state’s out-of-competition drug testing has other implications.
A New York Supreme Court ruling regarding that state’s out-of-competition drug testing has other implications.
Thoroughbred horsemen’s groups are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
A KHRC advisory panel approved a recommendation to prohibit the race day use of adjunct bleeder medications.
The New York State Racing and Wagering Board regulations on out-of-competition testing require nullification.
The Jockey Club reiterated its calls for a ban of Salix but made it clear it wants medication-free racing.
BloodHorse.com’s Jason Shandler caught up with Mike Repole to get his opinion on the current Salix debate.
The AGSC will employ a program banning race-day medications in graded 2-year-old Thoroughbred stakes races.
The RMTC will continue to study a pilot program proposal to ban the use of Salix in 2-year-old Thoroughbreds.
The KHRC’s new laboratory choice and decision to revamp testing protocol are yielding positive results.
The KHRC has begun reviewing and revising the state’s horse racing medication regulations.
The National Horsemen’s Benevolent and Protective Association supports elimination of race-day medications
On July 27 the Association of Racing Commissioners International (RCI) board of directors will consider
Florida Thoroughbred racing regulators have a goal of phasing out use of legal race-day medications like Salix
The National Reining Horse Association (NRHA) Board of Directors recently voted to approve an Animal Welfare
An Association of Racing Commissioners International (RCI) committee will meet July 26 to hear opinions and
Breeders’ Cup officials announced that the use of race-day medication will be prohibited in World Championship
Stay on top of the most recent Horse Health news with
